Illumina technology is pioneering genetic disease research,
helping to advance breakthroughs in genetic health. With the
significant impact of genetic disease and rare disease conditions
on individuals of all ages and families worldwide, our focus is to
develop solutions to facilitate early detection and intervention.
This can help improve outcomes, promotes enduring good health, and
raises awareness about the importance of one's genetic health. Our
targeted gene panels, microarrays, and next-generation sequencing
technologies can help genetic disease researchers identify
causative genetic variants and chromosomal aberrations, and may
enable early discovery.
To learn more, visit
www.illumina.com and follow @illumina.